Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 22, 2017

DrugPatentWatch Database Preview

Terbutaline sulfate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for terbutaline sulfate and what is the scope of terbutaline sulfate patent protection?

Terbutaline sulfate
is the generic ingredient in four branded drugs marketed by Sanofi Aventis Us, United Biomedcl, Hikma Farmaceutica, Ani Pharms Inc, Akorn, Lannett, Teva Pharms Usa, Novartis, Athenex Inc, Pharmacare, Impax Labs, and Fresenius Kabi Usa, and is included in fourteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for terbutaline sulfate. Thirteen suppliers are listed for this compound.

Summary for Generic Name: terbutaline sulfate

Tradenames:4
Patents:1
Applicants:12
NDAs:14
Drug Master File Entries: see list7
Suppliers / Packagers: see list13
Bulk Api Vendors: see list67
Clinical Trials: see list282
Patent Applications: see list4,503
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:terbutaline sulfate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis
BRETHAIRE
terbutaline sulfate
AEROSOL, METERED;INHALATION018762-001Aug 17, 1984DISCNNoNo► Subscribe► Subscribe
Lannett
TERBUTALINE SULFATE
terbutaline sulfate
TABLET;ORAL077152-001Mar 25, 2005RXNoNo► Subscribe► Subscribe
Hikma Farmaceutica
TERBUTALINE SULFATE
terbutaline sulfate
INJECTABLE;INJECTION078630-001May 20, 2009APRXNoNo► Subscribe► Subscribe
Athenex Inc
TERBUTALINE SULFATE
terbutaline sulfate
INJECTABLE;INJECTION076770-001Apr 23, 2004APRXNoYes► Subscribe► Subscribe
Fresenius Kabi Usa
TERBUTALINE SULFATE
terbutaline sulfate
INJECTABLE;INJECTION076887-001May 26, 2004APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Uncover prior art in abandoned patent applications and expired patents
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot